Correspondence
Hepatic Arterial Infusion after Liver Resection
N Engl J Med 2005; 352:734-735February 17, 2005
- Article
To the Editor:
In 1999, we reported on the results of a randomized study of adjuvant therapy after liver resection for metastatic colorectal cancer.1 One group of patients was treated with hepatic arterial infusion with floxuridine and dexamethasone plus systemic fluorouracil, with or without leucovorin (combined therapy). The other group received systemic therapy alone, consisting of fluorouracil with or without leucovorin (monotherapy). We reported an increase in two-year survival for the combined-therapy group as compared with the group receiving monotherapy. We also reported a significant increase in the rate of survival free of hepatic progression in the combined-therapy group. All patients have now been followed for a minimum of 6 years, with a median follow-up of 10.3 years. Overall progression-free survival is now significantly greater in the combined-therapy group than in the monotherapy group (31.3 vs. 17.2 months, P=0.02). The median survival free of hepatic progression has not yet been reached in the combined-therapy group, whereas it has reached 32.5 months in the monotherapy group (P<0.01). Median overall survival is now 68.4 months (95 percent confidence interval, 55.2 to not reached) in the group receiving combined therapy and 58.8 months (95 percent confidence interval, 42.0 to 85.2) in the monotherapy group (P=0.10). Ten-year survival rates are 41.1 percent and 27.2 percent, respectively (Figure 1Figure 1
Overall Survival among Patients with Metastatic Colorectal Cancer Who Were Treated with Hepatic Arterial Infusion plus Systemic Chemotherapy (Combined Therapy) or with Systemic Chemotherapy Alone (Monotherapy).). Toxicity since our first report includes late biliary toxic effects in two additional patients.When patients were stratified with the use of a clinical-risk scoring system2 that predicts the outcome after hepatic resection, those with a score of 0 to 2 had a similar median survival (83.3 months for the combined-therapy group and 82.8 months for the monotherapy group). By contrast, patients with a high risk of recurrence (a score of 3 to 5) had a median survival of 60.0 months in the combined-therapy group and 38.3 months in the monotherapy group (P=0.13) and a 10-year survival rate of 38.7 percent in the combined-therapy group and 16.3 percent in the monotherapy group. Although the study was not powered for five-year survival, there was improved progression-free survival and survival free of hepatic progression, and a trend toward an improved long-term outcome in the group receiving combined therapy, with a survival rate of approximately 40 percent at 10 years, even among patients with the greatest risk of recurrence.
2 ReferencesNancy E. Kemeny, M.D.
Mithat Gonen, Ph.D.
Memorial Sloan-Kettering Cancer Center, New York, NY 100211
Kemeny N ,Huang Y ,Cohen AM , et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999;341:2039-2048
Full Text | Web of Science | Medline2
Fong Y ,Fortner J ,Sun RL ,Brennan MF ,Blumgart LH . Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999;230:309-321
CrossRef | Web of Science | Medline
- Citing Articles (51)
Citing Articles
1
Bertrand Janne d'Othée, Constantinos T. Sofocleous, Nader Hanna, Robert J. Lewandowski, Michael C. Soulen, Jean-Nicolas Vauthey, Steven J. Cohen, Alan P. Venook, Matthew S. Johnson, Andrew S. Kennedy, Ravi Murthy, Jean-Francois Geschwind, Stephen T. Kee. (2012) Development of a Research Agenda for the Management of Metastatic Colorectal Cancer: Proceedings from a Multidisciplinary Research Consensus Panel. Journal of Vascular and Interventional Radiology 23:2, 153-163
CrossRef2
E. Seront, M. Van den Eynde. (2012) Liver-Directed Therapies: Does It Make Sense in the Current Therapeutic Strategy for Patients With Confined Liver Colorectal Metastases?. Clinical Colorectal Cancer
CrossRef3
Michael G. House, Nancy E. Kemeny, Mithat Gönen, Yuman Fong, Peter J. Allen, Philip B. Paty, Ronald P. DeMatteo, Leslie H. Blumgart, William R. Jarnagin, Michael I. D’Angelica. (2011) Comparison of Adjuvant Systemic Chemotherapy With or Without Hepatic Arterial Infusional Chemotherapy After Hepatic Resection for Metastatic Colorectal Cancer. Annals of Surgery1
CrossRef4
Marco Zoccali, Mukta Krane, Alessandro Fichera. (2011) Updates on Rectal Cancer. Current Colorectal Cancer Reports 7:3, 200-210
CrossRef5
John S. Bolton, Michael J. O'Connell, Michelle R. Mahoney, Gist H. Farr, Tom R. Fitch, William J. Maples, David M. Nagorney, Joseph Rubin, Jyotsna Fuloria, Preston D. Steen, Steven R. Alberts. (2011) Hepatic Arterial Infusion and Systemic Chemotherapy After Multiple Metastasectomy in Patients With Colorectal Carcinoma Metastatic to the Liver: A North Central Cancer Treatment Group (NCCTG) Phase II Study, 92-46-52. Clinical Colorectal Cancer
CrossRef6
Yunlong Cui, Huikai Li, Qiang Wu, Ti Zhang, Dalu Kong, Tianqiang Song, Tao Ru, Ping Chen, Qiang Li. (2011) Treatment of Colorectal Cancer with Unresectable Synchronous Liver-Only Metastases with Combined Therapeutic Modalities. Journal of Gastrointestinal Surgery 15:2, 285-293
CrossRef7
Nancy E. Kemeny, Lawrence Schwartz, Mithat Gönen, Adam Yopp, David Gultekin, Michael I. D’Angelica, Yuman Fong, Dana Haviland, Alexandra N. Gewirtz, Peter Allen, William R. Jarnagin. (2011) Treating Primary Liver Cancer with Hepatic Arterial Infusion of Floxuridine and Dexamethasone: Does the Addition of Systemic Bevacizumab Improve Results?. Oncology 80:3-4, 153-159
CrossRef8
Nabil Ismaili. (2011) Treatment of colorectal liver metastases. World Journal of Surgical Oncology 9:1, 154
CrossRef9
T. Peter Kingham, Michael D'Angelica, Nancy E. Kemeny. (2010) Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases. Journal of Surgical Oncology 102:8, 988-995
CrossRef10
Luis H. Camacho, Sheila Garcia, Amar M. Panchal, JoAnn Lim, David S. Hong, Chaan Ng, David C. Madoff, Siqing Fu, Isis Gayed, Razelle Kurzrock. (2010) Exploratory Study of Hepatic Arterial Infusion Oxaliplatin With Systemic 5-Fluorouracil/Bevacizumab in Patients With Refractory Solid Tumor and Extensive Liver Metastases. Clinical Colorectal Cancer 9:5, 311-314
CrossRef11
Nancy Kemeny. (2010) The management of resectable and unresectable liver metastases from colorectal cancer. Current Opinion in Oncology 22:4, 364-373
CrossRef12
David J. Gallagher, Nancy Kemeny. (2010) Improving Response and Outcomes for Patients With Liver-Limited Metastatic Colorectal Cancer. Clinical Colorectal Cancer 9:0, S36-S43
CrossRef13
Mahmoud N. Kulaylat, John F. Gibbs. (2010) Regional treatment of colorectal liver metastasis. Journal of Surgical Oncology 101:8, 693-698
CrossRef14
Laura Raftery, Richard M. Goldberg. (2010) Optimal Delivery of Cytotoxic Chemotherapy for Colon Cancer. The Cancer Journal 16:3, 214-219
CrossRef15
Joleen M. Hubbard, Steven R. Alberts. (2010) Treatment of Liver-Limited Metastatic Colorectal Cancer. The Cancer Journal 16:3, 235-240
CrossRef16
Michael G. House, Hiromichi Ito, Mithat Gönen, Yuman Fong, Peter J. Allen, Ronald P. DeMatteo, Murray F. Brennan, Leslie H. Blumgart, William R. Jarnagin, Michael I. D'Angelica. (2010) Survival after Hepatic Resection for Metastatic Colorectal Cancer: Trends in Outcomes for 1,600 Patients during Two Decades at a Single Institution. Journal of the American College of Surgeons 210:5, 744-752
CrossRef17
Derek G. Power, Stuart M. Lichtman. (2010) Chemotherapy for the Elderly Patient With Colorectal Cancer. The Cancer Journal 16:3, 241-252
CrossRef18
Roberto Labianca, Giordano D. Beretta, Basem Kildani, Laura Milesi, Federica Merlin, Stefania Mosconi, M. Adelaide Pessi, Tiziana Prochilo, Antonello Quadri, Gemma Gatta, Filippo de Braud, Jacques Wils. (2010) Colon cancer. Critical Reviews in Oncology/Hematology 74:2, 106-133
CrossRef19
John B. Ammori, Nancy E. Kemeny. (2010) Regional Hepatic Chemotherapies in Treatment of Colorectal Cancer Metastases to the Liver. Seminars in Oncology 37:2, 139-148
CrossRef20
Thinn P. Pwint, Rachel Midgley, David J. Kerr. (2010) Regional Hepatic Chemotherapies in the Treatment of Colorectal Cancer Metastases to the Liver. Seminars in Oncology 37:2, 149-159
CrossRef21
Margaret K. Callahan, Nancy E. Kemeny. (2010) Implanted Hepatic Arterial Infusion Pumps. The Cancer Journal 16:2, 142-149
CrossRef22
, Paula Manchon Walsh, Josep M. Borràs, Tàrsila Ferro, Josep Alfons Espinàs. (2010) Colorectal cancer OncoGuia. Clinical and Translational Oncology 12:3, 188-210
CrossRef23
Mohamed Hebbar, François-René Pruvot, Olivier Romano, Jean-Pierre Triboulet, Aimery de Gramont. (2009) Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer. Cancer Treatment Reviews 35:8, 668-675
CrossRef24
Archie N. Tse, Nian Wu, Dina Patel, Dana Haviland, Nancy Kemeny. (2009) A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies. Cancer Chemotherapy and Pharmacology 64:5, 935-944
CrossRef25
N. Kemeny, M. Capanu, M. D'Angelica, W. Jarnagin, D. Haviland, R. Dematteo, Y. Fong. (2009) Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Annals of Oncology 20:7, 1236-1241
CrossRef26
James H. Muchmore, Harold J. Wanebo. (2008) Regional Chemotherapy: Overview. Surgical Oncology Clinics of North America 17:4, 709-730
CrossRef27
Don S. Dizon, Joanna Schwartz, Nancy Kemeny. (2008) Regional Chemotherapy: A Focus on Hepatic Artery Infusion for Colorectal Cancer Liver Metastases. Surgical Oncology Clinics of North America 17:4, 759-771
CrossRef28
Jacques Barbet, Françoise Kraeber-Bodéré, Jean-François Chatal. (2008) Review: What Can Be Expected from Nuclear Medicine Tomorrow?. Cancer Biotherapy & Radiopharmaceuticals 23:4, 483-504
CrossRef29
Dan S. Zuckerman, Jeffrey W. Clark. (2008) Systemic therapy for metastatic colorectal cancer. Cancer 112:9, 1879-1891
CrossRef30
Cletus A. Arciero, Elin R. Sigurdson. (2008) Diagnosis and Treatment of Metastatic Disease to the Liver. Seminars in Oncology 35:2, 147-159
CrossRef31
Su-Pin Choo, Alan P. Venook. (2008) Hepatic artery infusion in the treatment of colorectal cancer metastases. Current Colorectal Cancer Reports 4:2, 106-113
CrossRef32
Steven R. Alberts. (2008) Use of neoadjuvant and postoperative chemotherapy with surgical resection of colorectal cancer hepatic metastases. Current Colorectal Cancer Reports 4:2, 100-105
CrossRef33
Bernardo Sandoval, Yuman Fong. (2008) Adjuvant Therapy after Resection of Hepatic Colorectal Metastases. Annals of Surgical Oncology 15:1, 9-10
CrossRef34
X Wang, D L Hershman, J A Abrams, D Feingold, V R Grann, J S Jacobson, A I Neugut. (2007) Predictors of survival after hepatic resection among patients with colorectal liver metastasis. British Journal of Cancer 97:12, 1606-1612
CrossRef35
Silke Lassmann, Laura Tang, Marinela Capanu, Thomas Brabletz, Anja Schöpflin, Axel Zur Hausen, Mithat Gonen, Nancy Kemeny, Jinru Shia, David Klimstra, Martin Werner. (2007) Predictive Molecular Markers for Colorectal Cancer Patients With Resected Liver Metastasis and Adjuvant Chemotherapy. Gastroenterology 133:6, 1831-1839
CrossRef36
Torsten Liersch, Johannes Meller, Michael Bittrich, Bettina Kulle, Heinz Becker, David M. Goldenberg. (2007) Update of Carcinoembryonic Antigen Radioimmunotherapy with 131I-Labetuzumab After Salvage Resection of Colorectal Liver Metastases: Comparison of Outcome to a Contemporaneous Control Group. Annals of Surgical Oncology 14:9, 2577-2590
CrossRef37
Vikas Aurora, Mary F. Mulcahy. (2007) Adjuvant therapy for resectable liver metastases: Can metastatic colorectal cancer be cured?. Current Colorectal Cancer Reports 3:3, 127-134
CrossRef38
Luis H. Camacho, Razelle Kurzrock, Alex Cheung, Diane F. Barber, Sanjay Gupta, David C. Madoff, Michael J. Wallace, E. Edmund Kim, Steven A. Curley, Gabriel N. Hortobagyi, Giora Mavligit. (2007) Pilot study of regional, hepatic intra-arterial paclitaxel in patients with breast carcinoma metastatic to the liver. Cancer 109:11, 2190-2196
CrossRef39
M. Dicato, S. Cherrier, E. Custsem, G. Berchem. (2007) Postsurgical surveillance: How intensive should it be?. Current Colorectal Cancer Reports 3:1, 35-38
CrossRef40
Volker Heinemann, Ernst J. Rummeny, Wolfram Trudo Knoefel, Andrea Tannapfel, Anke Reinacher-Schick. (2007) Management von Lebermetastasen. Onkologie 30:2, 5-12
CrossRef41
Thomas Weber, Karl Heinz Link. (2007) Radikale Chirurgie bei primär metastasierten kolorektalen Karzinomen. Chirurgische Gastroenterologie 23:4, 360-366
CrossRef42
Marc J. Gollub, Lawrence H. Schwartz, Tim Akhurst. (2007) Update on Colorectal Cancer Imaging. Radiologic Clinics of North America 45:1, 85-118
CrossRef43
K MORRIS, T SONG, Y FONG. (2006) Recent advancements in diagnosis and treatment of metastatic colorectal cancer to the liver. Surgical Oncology 15:3, 129-134
CrossRef44
David L. Bartlett, Jordan Berlin, Gregory Y. Lauwers, Wells A. Messersmith, Nicholas J. Petrelli, Alan P. Venook. (2006) Chemotherapy and Regional Therapy of Hepatic Colorectal Metastases: Expert Consensus Statement. Annals of Surgical Oncology 13:10, 1284-1292
CrossRef45
Smitha Patiyil, Steven R. Alberts. (2006) Metastatic colorectal cancer: Therapeutic options. Current Treatment Options in Oncology 7:5, 389-398
CrossRef46
Bridget N. Fahy, William R. Jarnagin. (2006) Evolving Techniques in the Treatment of Liver Colorectal Metastases: Role of Laparoscopy, Radiofrequency Ablation, Microwave Coagulation, Hepatic Arterial Chemotherapy, Indications and Contraindications for Resection, Role of Transplantation, and Timing of Chemotherapy. Surgical Clinics of North America 86:4, 1005-1022
CrossRef47
Robert J. Downey. (2006) Surgery for Colorectal and Sarcomatous Pulmonary Metastases: History, Current Management, and Future Directions. Thoracic Surgery Clinics 16:2, 133-137
CrossRef48
Steven R. Alberts. (2006) Neoadjuvant and adjuvant therapy combined with resection of hepatic colorectal cancer metastases. Current Colorectal Cancer Reports 2:2, 81-84
CrossRef49
M. Margaret Kemeny. (2006) Expressing the Surgery First Position on Treatment of Synchronous Colorectal Metastases in the Asymptomatic Patient. Annals of Surgical Oncology 13:2, 140-141
CrossRef50
T.-J. Song, P. Adusumilli, Y. Fong. (2005) Prognostische Faktoren kolorektaler Lebermetastasen. Der Chirurg 76:6, 535-542
CrossRef51
Mohamed Hebbar. (2005) Chemotherapy in patients with resectable liver metastases from colorectal cancer. Current Colorectal Cancer Reports 1:1, 34-40
CrossRef
